Newly Innovated Nanoparticle Vaccines Demonstrate Potentiality to Curb Down Various Cancers, Zika Virus By Soutrik Das | Apr 25, 2017 08:12 AM EDT A new nanoparticle therapy has been developed by a group of scientists for cancer elimination. A group of researchers has recently developed a first of its kind that targets to resolve nanoparticle different cancer types. The team belonging from UT Southwestern Medical Center has innovated a synthetic polymer nanoparticle, inside which insists a sort of tumor antigens, which is made out of tumor protein recognizable to the immune system. According to Science Daily, the nanoparticle-based vaccine has the capacity of driving minuscule particulates to the immune system for the development of an immune response. This immune response holds up the responsibility for striking down damaged cells which later converts into cancer. Dr. Jinming Gao, a Professor of Pharmacology and Otolaryngology in UT Southwestern's Harold C. Simmons Comprehensive Cancer Center, said: "What is unique about our design is the simplicity of the single polymer composition that can precisely deliver tumor antigens to immune cells while stimulating innate immunity. These actions result in safe and robust production of tumor-specific T cells that kill cancer cells," Watch video As per a report by ReliaWire, earlier this year another team of researchers evolved a similar kind of RNA-based nanoparticle which can provide vaccination to potential candidates suffering from Zika Virus. This nanoparticle filled with messenger RNA provides fresh RNA particles to cell thereby disrupting the activity of Zika virus in the human body, which has terrified enough amount of pregnant women in the U.S. The newest innovation of nanoparticles, which has the protecting capacity from cancer, stimulates immune cells to collect tumor antigens in a "depot system." And thereby moves directly to the lymphoid organs of cancer affected the body and activates the immune responses at the required areas by activating specific T Cells. The new innovation surfaced promising advancements in the road to cancer research.